Cargando…

CIAS1-associated autoinflammatory syndrome first diagnosed at age 48 years: a case report

Detalles Bibliográficos
Autores principales:	Fasshauer, M, Borte, S, Hauenherm, A, Braun, E, Reichenbach, H, Borte, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599762/ http://dx.doi.org/10.1186/1546-0096-13-S1-P211

Ejemplares similares

Diversity in clinical manifestations of autoinflammatory syndromes
por: Boiu, S, et al.
Publicado: (2011)

The Eurofever Registry for autoinflammatory diseases: results of the first 15 months of enrolment
por: Toplak, N, et al.
Publicado: (2011)

Recommendations for the management of autoinflammatory diseases
por: ter Haar, N, et al.
Publicado: (2015)

Unexplained recurrent arthritis as presenting sign of hereditary autoinflammatory syndromes
por: Zulian, F, et al.
Publicado: (2011)

Somatic mosaicism of CIAS1/NLRP3 gene in two patients with chronic infantile neurologic, cutaneous, articular syndrome
por: Pastore, Serena Ifmach-i, et al.
Publicado: (2014)

NLRP12- associated autoinflammatory disorder: case report
por: Volpe, Giuseppina, et al.
Publicado: (2014)

Development of the autoinflammatory disease damage index (ADDI)
por: Annink, K, et al.
Publicado: (2015)

Monogenetic autoinflammatory syndromes and nephrology - therapy is usefull even in advanced kidney failure
por: Hohenstein-Scheibenecker, K, et al.
Publicado: (2015)

Therapy of autoinflammatory diseases: a review of the literature
por: ter Haar, NM, et al.
Publicado: (2011)

Canakinumab for the treatment of different refractory autoinflammatory disorders
por: Grein, Ingrid HR, et al.
Publicado: (2014)

Familial Mediterranean Fever and Human autoinflammatory diseases
por: Hovhannisyan, L
Publicado: (2015)

Therapy of autoinflammatory diseases: results from an international registry
por: ter Haar, NM, et al.
Publicado: (2011)

PReS-FINAL-2210: Qualitative aspects of autoinflammatory diseases
por: Konukbay, D, et al.
Publicado: (2013)

Development and validation of juvenile autoinflammatory disease multidimensional assessment report (JAIMAR)
por: Konukbay, D, et al.
Publicado: (2015)

PReS-FINAL-2236: Continuous autoinflammatory syndromes: a single-center experience in Argentina
por: Russo, RA, et al.
Publicado: (2013)

A heterozygous variant in MEFV in a familial autoinflammatory syndrome with PAPA-like features
por: Jéru, I, et al.
Publicado: (2015)

PReS-FINAL-2329: Validation of the autoinflammatory activity index (AIDAI)
por: Piram, M, et al.
Publicado: (2013)

Targeted NGS based hereditary autoinflammatory disorder screening in routine diagnostics, two year experience in the Netherlands
por: Elferink, MG, et al.
Publicado: (2015)

Prospective validation of the diagnostic score for molecular analysis of hereditary autoinflammatory syndromes in Italian children with periodic fever
por: Federici, S, et al.
Publicado: (2008)

PReS-FINAL-2199: A novel mutation in the CIAS1/NLRP3 gene associated with an unusual phenotype of CAPS
por: Insalaco, A, et al.
Publicado: (2013)

Clinical experiences with canakinumab as a treatment for autoinflammatory disorders
por: Saperia, C, et al.
Publicado: (2015)

Neurological manifestations in autoinflammatory syndromes: a series of 131 patients from our neuroimmunology departement
por: Schuh, E, et al.
Publicado: (2015)

Interleukin-1-related cytokines as potential biomarkers in autoinflammatory skin diseases
por: Bonnekoh, H, et al.
Publicado: (2015)

First report of OXA-48 carbapenemase-producing Escherichia coli in Taiwan
por: Jao, Y, et al.
Publicado: (2015)

A validation of diagnostic score for molecular analysis of hereditary autoinflammatory syndromes with periodic fever in Turkish children
por: Demirkaya, Erkan, et al.
Publicado: (2011)

Serum IL-18 is a specific biomarker for Macrophage Activation Syndrome across several autoinflammatory diseases
por: Canna, SW, et al.
Publicado: (2015)

A case of neonatal-onset autoinflammatory syndrome with a de novo PSMB9 mutation resembling Nakajo-Nishimura syndrome
por: Kinjo, N, et al.
Publicado: (2015)

IL-1 blockade as a novel approach to treatment of hyperzincemia and hypercalprotectinemia, a possible new autoinflammatory syndrome
por: Lionetti, Geraldina, et al.
Publicado: (2012)

Different pattern of synthesis and secretion of IL-1beta in patients with CIAS-1 and TNFRSF1A mutations responding to IL-1 blockade
por: Lasigliè, D, et al.
Publicado: (2008)

Determinants of health-related quality of life in children and adults with autoinflammatory diseases
por: Erbis, G, et al.
Publicado: (2015)

Studying patients with autoinflammatory diseases: the past, present, and a perspective for the future
por: Hausmann, JS, et al.
Publicado: (2015)

PReS-FINAL-2237: The diagnostic challenge of osteolytic bone lesions in autoinflammatory diseases: a case report
por: Caorsi, R, et al.
Publicado: (2013)

A case of systemic juvenile idiopathic arthritis with pulmonary hemosiderosis secondary to recurrent macrophage activation syndrome or a new autoinflammatory syndrome?
por: Barut, K, et al.
Publicado: (2015)

Clavicular cortical hyperostosis: new autoinflammatory entity or part of the juvenile spondyloarthropathies clinical picture?
por: Lamot, L, et al.
Publicado: (2011)

Single center experience in Next Generation Sequencing for genetic diagnosis of Autoinflammatory Disorders (AIDs)
por: Lepri, FR, et al.
Publicado: (2015)

A novel mutation in NLRC4 in a large pedigree with an anakinra responsive autoinflammatory disease
por: Volker-Touw, N, et al.
Publicado: (2015)

Anti-interleukin 1 treatment in secondary renal amyloidosis associated with autoinflammatory diseases
por: Topaloglu, R, et al.
Publicado: (2015)

Implementation of home measurement of CRP levels in diagnosis and monitoring of children with autoinflammatory diseases
por: Wolska-Kuśnierz, B, et al.
Publicado: (2015)

Anakinra as a diagnostic challenge and treatment option for systemic autoinflammatory disorders of undefined genetic cause
por: Harrison, S, et al.
Publicado: (2015)

Phase III, multi-centre, randomised, double blind, Placebo-controlled study for treatment of juvenile ankylosing spondylitis (AS) with Adalimumab
por: Horneff, G, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_1i9g842ncts4igsds7r5lb2ctl